A causal approach to analysis of censored medical costs in the presence of time-varying treatment
Andrew J. Spieker, Arman Oganisian, Emily M. Ko, Jason A. Roy, and, Nandita Mitra

TL;DR
This paper introduces a causal inference method using nested g-computation to analyze censored medical costs with time-varying treatments, addressing a gap in existing approaches for policy-relevant cost comparisons.
Contribution
It develops a novel nested g-computation approach that handles time-dependent treatments and confounding in censored cost data, improving causal effect estimation.
Findings
Method is robust to distributional assumption violations.
Provides insights into cost differences across treatment regimes.
Addresses a gap in causal analysis of censored medical costs.
Abstract
There has recently been a growing interest in the development of statistical methods to compare medical costs between treatment groups. When cumulative cost is the outcome of interest, right-censoring poses the challenge of informative missingness due to heterogeneity in the rates of cost accumulation across subjects. Existing approaches seeking to address the challenge of informative cost trajectories typically rely on inverse probability weighting and target a net "intent-to-treat" effect. However, no approaches capable of handling time-dependent treatment and confounding in this setting have been developed to date. A method to estimate the joint causal effect of a treatment regime on cost would be of value to inform public policy when comparing interventions. In this paper, we develop a nested g-computation approach to cost analysis in order to accommodate time-dependent treatment…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Health Systems, Economic Evaluations, Quality of Life · Statistical Methods in Clinical Trials
